EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 29-Oct-2026 06:16 ET (29-Oct-2026 10:16 GMT/UTC)

SWOG Cancer Research Network and The Hope Foundation for Cancer Research launch initiative to expand veterans’ access to cancer clinical trials

The Hope Foundation for Cancer Research
Business Announcement

SWOG Cancer Research Network and The Hope Foundation for Cancer Research have announced the launch of the Dr. Charles D. Blanke Veterans Access to Cancer Trials Initiative, an effort dedicated to expanding access to cancer clinical trials for U.S. military veterans. The initiative formalizes and builds upon more than a decade of collaborative work to strengthen Veterans Affairs Medical Center (VAMC) participation in the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN) and NCI Community Oncology Research Program (NCORP).

Researchers find potential one-two punch against triple-negative breast cancer

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme – RNase H2 – that helps triple-negative breast cancer (TNBC) cells survive high levels of DNA replication stress. Because many breast cancer therapies work by causing replication stress, these results suggest RNase H2 is a promising treatment target.

Journal: Cell Reports Medicine

ALK mutation: A predictive biomarker for pan-cancer immunotherapy

Compuscript Ltd
Peer-Reviewed Publication

Immune checkpoint blockade (ICB) targeting pathways like PD-1, PD-L1, and CTLA-4 has revolutionized cancer treatment, but determining which patients will benefit remains a significant clinical challenge. Previous research established the anaplastic lymphoma kinase (ALK) gene as a key oncogenic driver, but the role of immunotherapy in patients with ALK-altered tumors has been controversial, particularly due to the profound heterogeneity between ALK rearrangements and somatic mutations

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China

New treatment with fewer side effects reduces breast density

Karolinska Institutet
Peer-Reviewed Publication

Low doses of the investigational medicinal product endoxifen reduce breast density to the same extent as the standard treatment tamoxifen, but without causing such troublesome side effects. This is shown by a new study from Karolinska Institutet published in the Journal of the National Cancer Institute. The results may have implications for future preventive treatment of breast cancer.

Journal: JNCI Journal of the National Cancer Institute

Promising new technique uses nanoparticles to detect pancreatic cancer

Oregon Health & Science University
Peer-Reviewed Publication

Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.

Journal: Small
Funder: Pancreatic Cancer Detection Consortium

Blood stem cells evade immunity in aplastic anemia by similar genetic mutations arising independently

St. Jude Children's Research Hospital
Peer-Reviewed Publication

A genomic study of the largest pediatric and adult aplastic anemia cohort genetically profiled to date, finds that protective mutations arise as independent events in different stem cells years before diagnosis.

Journal: Nature Genetics

How a cell doubles its DNA matters more than we thought

Hokkaido University
Peer-Reviewed Publication

A new study shows that how a cell fails to divide after copying its DNA can determine its fate.

Journal: Proceedings of the National Academy of Sciences
Funder: Japan Society for the Promotion of Science, Princess Takamatsu Cancer Research Fund, Kato Memorial Bioscience Foundation, The Orange Foundation, Smoking Research Foundation, Daiichi Sankyo Foundation of Life Science, Akiyama Life Science Foundation, Hoansha Foundation, Sumitomo Electric Group CSR Foundation, Terumo Life Science Foundation

Cervical cancer: A growing gap between high- and low-income countries

Université Laval
Peer-Reviewed Publication

While high-income countries like Canada could eliminate cervical cancer by 2048 through human papillomavirus (HPV) vaccination and screening, the gap with lower-income countries is widening. A study published in The Lancet by a team from Université Laval and the CHU de Québec – Université Laval Research Center shows that these inequalities could skyrocket within a few decades if nothing changes in terms of prevention.

Journal: The Lancet

Dana-Farber experts offer perspective on link between pesticide exposure and early-onset colorectal cancer

Dana-Farber Cancer Institute
Peer-Reviewed Publication

Advanced technologies are helping researchers identify environmental contaminants that could potentially be contributing to the rising incidence of early-onset colorectal cancer. However, epigenetic studies on such associations should be interpreted with caution, according to researchers at Dana-Farber Cancer Institute, who are leading experts in the disease.

Journal: Nature Medicine

Novel theranostic approach for radioimmunotherapy achieves curative responses in colorectal cancer tumors

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a preclinical colorectal cancer model. The multi-step theranostic approach delivers alpha-emitting radiation directly to tumors while limiting exposure to healthy tissues. This research was published in the May issue of The Journal of Nuclear Medicine.

Journal: Journal of Nuclear Medicine